
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Breast lumps diagnostic study of choice
Introduction
Overview
Overview
Mammography is the gold standard test for the diagnosis of breast lumps in women aged >40 years old. Ultrasound is the gold standard test for the diagnosis of breast lumps in women aged <40 years old. Management and medical therapy of breast lumps depends on women’s age (age> 40 or age <40) and mammography results in women aged > 40 years. In women aged > 40 years; no further evaluation is needed in case of clearly benign mass in mammography; however, ultrasound imaging is required for the rest of the findings mammography. Approach to breast lumps in women >40 years is depended on breast imaging reporting and data systems (BI-RADS) stages. Medical therapy of breast lumps in women< 40 years is depended on ultrasound results and BI-RADS categories.
Diagnostic Study of Choice
Diagnostic Study of Choice
Gold Standard
Mammography
Mammography is the gold standard test for the diagnosis of breast lumps in women aged >40 years old.[1]
- If the patient had positive history of bilateral mammography within past 6 months, only ipsilateral mammography is needed.
Ultrasound
Ultrasound is the gold standard test for the diagnosis of breast lumps in women aged <40 years old.[1]
The comparison of various diagnostic studies for breast lumps:[2]
| Sensitivity | Specificity | |
|---|---|---|
| Ultrasound | 82% | 84% |
| Mammography | 49% | 89% |
Breast ultrasound has higher sensitivity and mammography has higher specificity. The accuracy of ultrasound reported as 84% and accuracy of mammography reported as 81% .[2]
Diagnostic Approach to Breast Lump
Diagnostic approach for breast lump:
- Women aged >40 years with palpable mass:[3]
- Diagnostic mammography is considered as the first step.
- If the last screening test is related to more than previous 6 months, both breast mammography is required to rule out occult malignancy.
- No further evaluation is needed in case of clearly benign mass in mammography.
- Ultrasound imaging is required for the rest of cases appeared in mammography.
- Stereotactic biopsy is recommended in negative ultrasound findings addition to suspicious mammographic results.
- Women aged< 40 years with palpable mass:[1][4]
- Ultrasound or mammography is suggested for initial management of women aged between 30 to 39 years.
- Ultrasound is the first step for women < 30 years presenting with palpable mass.
Approach to breast lumps in women aged > 40 years based on mammographic results:[3]
- If mammographic results become negative, the next step is targeted ultrasound.
- Negative ultrasound results considered as breast imaging reporting and data system (BI-RADS) 1, then clinical follow-up is needed.
- Benign ultrasound results considered as BI-RADS 2, then clinical follow-up is needed.
- Probably benign results considered as BI-RADS 3, then ultrasound short interval follow-up is needed.
- Suspicious ultrasound results considered as BI-RADS 4 or 5, then core-needle biopsy is needed.
- If mammographic results show only fatty tissue:
- Considered as BI-RADS 1, then clinical follow-up is needed.
- If mammographic results show benign mass:
- Considered as BI-RADS 2, then clinical follow-up
- If mammographic results are in favor of probably benign lumps, the next step is targeted ultrasound.
- Negative ultrasound results considered as BI-RADS 3, then mammographic short interval follow-up is required.
- Benign ultrasound results considered as BI-RADS 2, then clinical follow-up is required.
- Probably benign ultrasound results considered as BI-RADS 3, then ultrasound short interval follow-up.
- Suspicious ultrasound results is considered as BI-RADS 4 or 5, then core needle biopsy is required.
- If mammographic result is in favor of suspicious lesion, the next step is ultrasound to determine biopsy plan.
- Considered as BI-RADS 4 or 5, then core needle biopsy is required.
Approach to breast lumps in women aged <40 years based on targeted ultrasound findings:[3]
- If ultrasound results become negative, there are two approaches:
- Considered as BI-RADS 1, then clinical follow-up is required ( if no palpable dominant suspicious mass found at clinical examination)
- Perform diagnostic mammography:
- Negative results are in favor of BI-RADS 1, then clinical follow-up is required.
- Benign results are considered as BI-RADS 2, then clinical follow-up is required.
- Probably benign results considered as BI-RADS 3, Mammographic short interval follow-up is required.
- Suspicious results considered as BI-RADS 4 or 5, then core needle biopsy is required.
- If ultrasound results show benign findings:
- Considered as BI-RADS 2, then clinical follow-up is required.
- If ultrasound results show probably benign findings:
- Considered as BI-RADS 3, then short interval follow-up is required.
- If ultrasound results become suspicious:
- Considered as BI-RADS 4 or 5, then core needle biopsy is required.
For more information on breast imaging reporting and data system (BI-RADS) system, click here.
 |  |  |  |  |  |  |  |  | Women age > 40 years |  |  |  |  |  | |||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  | Mammographic findings |  |  |  |  |  | |||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||
 | Negative |  | Fatty tissue |  | Benign |  | Probably benign |  |  | Suspicious |  | ||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||
 | Ultrasound |  | BI-RADS 1, then clinical follow-up |  | BI-RADS 2, then clinical follow-up |  | Ultrasound |  |  | Ultrasound for biopsy plan determination | |||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | BI-RADS 4 or 5, then core needle biopsy | |||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||
 |  |  |  |  |  |  |  | Negative |  | Benign |  | Probably benign |  | Suspicious | |||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||
 |  |  |  |  |  |  |  | BI-RADS 3, then mammographic short interval follow-up |  | BI-RADS 2, then clinical follow-up |  | BI-RADS 3, then ultrasound short interval follow-up |  | BI-RADS 4 or 5, then core needle biopsy | |||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||
 | Negative results |  | Benign |  | Probably benign |  | Suspicious |  |  | ||||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||
 | BI-RADS 1, then clinical follow-up |  | BI-RADS 2, then clinical follow-up |  | BI-RADS 3, then ultrasound short interval follow-up |  | BI-RADS 4 or 5, then core needle biopsy |  |  | ||||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  | Women age < 40 years |  |  |  |  |  | |||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  | Targeted ultrasound |  |  |  |  |  | |||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||
 | Negative |  | Benign |  |  |  |  |  | Probably benign |  | Suspicious |  |  |  | |||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||
 |  |  |  |  |  | BI-RADS 2, then clinical follow-up |  |  |  |  |  | BI-RADS 3, then short interval follow-up |  | BI-RADS 4 or 5, then core needle biopsy | |||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||||||||||||
 |  |  |  |  |  | ||||||||||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||||||||||||
 | BI-RADS 1, then clinical follow-up |  |  | Perform diagnostic mammography | |||||||||||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||||||
 |  |  |  |  |  | Negative |  | Benign |  |  | Probably benign |  | Suspicious |  | |||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||
 |  |  |  |  |  | BI-RADS 1, then clinical follow-up |  | BI-RADS 2, then clinical follow-up |  |  | BI-RADS 3, Mammographic short interval follow-up |  | BI-RADS 4 or 5, then core needle biopsy | ||||||||||||||||||||||||||||||||
References
References
- ↑ 1.0 1.1 1.2 Lehman CD, Lee AY, Lee CI (2014). “Imaging management of palpable breast abnormalities”. AJR Am J Roentgenol. 203 (5): 1142–53. doi:10.2214/AJR.14.12725. PMID 25341156.
- ↑ 2.0 2.1 Tan KP, Mohamad Azlan Z, Rumaisa MP, Siti Aisyah Murni MR, Radhika S, Nurismah MI; et al. (2014). “The comparative accuracy of ultrasound and mammography in the detection of breast cancer”. Med J Malaysia. 69 (2): 79–85. PMID 25241817.
- ↑ 3.0 3.1 3.2 Harvey JA, Mahoney MC, Newell MS, Bailey L, Barke LD, D’Orsi C; et al. (2016). “ACR Appropriateness Criteria Palpable Breast Masses”. J Am Coll Radiol. 13 (11S): e31–e42. doi:10.1016/j.jacr.2016.09.022. PMID 27814822.
- ↑ Loving VA, DeMartini WB, Eby PR, Gutierrez RL, Peacock S, Lehman CD (2010). “Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications”. AJR Am J Roentgenol. 195 (6): 1472–7. doi:10.2214/AJR.10.4396. PMID 21098212.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
